A three-lncRNA signature predicts clinical outcomes in low-grade glioma patients after radiotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A three-lncRNA signature predicts clinical outcomes in low-grade glioma patients after radiotherapy

Published:2020-05-26 Issue:10 Volume:12 Page:9188-9204
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Lin Wanzun¹,Huang Zongwei²,Xu Yanyan³,Chen Xiaochuan²,Chen Ting⁴,Ye Yuling²,Ding Jianming¹,Chen Zhangjie⁴,Chen Long⁵,Qiu Xianxin⁶,Qiu Sufang²

Affiliation:

1. Department of Radiation Oncology, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, China

2. Department of Radiation Oncology, Fujian Medical University Cancer Hospital and Fujian Cancer Hospital, Fuzhou, China

3. Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

4. Department of Chemotherapy, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China

5. Division of Neurocritical Care, Huashan Hospital, Fudan University, Shanghai, China

6. Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Ageing

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multi-omics analysis-based model to predict the prognosis of low-grade gliomas;Scientific Reports;2024-04-24

2. DNA repair in tumor radioresistance: insights from fruit flies genetics;Cellular Oncology;2023-12-14

3. Unlocking the predictive potential of long non-coding RNAs: a machine learning approach for precise cancer patient prognosis;Annals of Medicine;2023-11-20

4. Exploration of the radiosensitivity-related prognostic risk signature in patients with glioma: evidence from microarray data;Journal of Translational Medicine;2023-09-12

5. Decreased SPTBN2 expression regulated by the ceRNA network is associated with poor prognosis and immune infiltration in low‑grade glioma;Experimental and Therapeutic Medicine;2023-04-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3